Med Ed Report briefs: December 2013

Share this article:
Risperdal
Risperdal

Bayer Healthcare, Onyx Pharmceuticals and Lilly sponsored a CME workshop series for oncologists and oncology nurses, offering guidance on treatment of solid tumors. ACCME-accredited firm Med-IQ is the provider on the presentations.

The probe that resulted in J&J's $2.2-billion settlement last month for alleged illegal marketing of Risperdal and other drugs also named several academic medical centers. ­According to the Chronicle of Higher Education, the probe fingered a list of more than 50 researchers at some two dozen mostly US universities who wrote articles for medical journals that J&J allegedly used to overstate the benefits and understate the risks of the drug.

CMS updated its frequently asked questions page on the Open Payments program—formerly known as the Physician Payment Sunshine Act, noted the blog Policy and Medicine. The page was updated with 20 new FAQs.

Community Care Behavioral Health Organization said it's offering a series of 12 web-based trainings for psychiatrists focusing on strategies to help improve health. The 30-minute presentations each come with free CME credits.

Share this article:

Email Newsletters

More in Features

Antidote: On Cystic Fibrosis treatments

Antidote: On Cystic Fibrosis treatments

Recent treatments in CF, including the inhaled antibiotic Tobramycin, have increased lifespan well into adulthood.

The $3 generic and the $1,000 pill: pharma outsiders just don't get it

The $3 generic and the $1,000 pill: pharma ...

What do you call the people who treat medical breakthroughs as if they were bank heists? Malicious? Uninformed? Not with it?

Leadership Exchange Uncut : The Agency-Client Relationship

Leadership Exchange Uncut : The Agency-Client Relationship

Click the above link to access MM&M's first Leadership Exchange Uncut e-book, "The Agency-Client Relationship"